If you saw the headline about Tan Su Shan selling S$6 million of DBS and nearly spilled your morning kopi, this episode is for you. We walk through what a 100,000‑share sale at around S$60 actually does to her skin in the game, and why it looks more like normal executive cashflow than a secret escape hatch. Then we zoom out to the real issue for a CPF and SRS investor: DBS trading above analyst fair value, a dividend yield that’s now only about 1% higher than CPF SA, and what that razor‑thin spread means for your retirement income. By the end, you’ll know whether to keep collecting DBS dividends like your neighbourhood ATM, or to stop topping up at today’s Bedok hawker‑stall prices and wait for the next discount day.
Key takeaways:
Why a 100,000‑share CEO sale is “liquidity trim”, not “run for the exits” panic
How DBS’s price has run ahead of analyst targets and what that means for upside left
Why a 5‑ish percent yield is dangerous when CPF SA already pays 4% with no equity swing
When accumulators should pause fresh DBS buys and wait for the yield to “breathe” again
Why retirees can keep drawing DBS dividends but must respect the thin risk premium now
Iggy’s Forensic Disclaimer
This content is produced for educational and informational purposes only. I am not a financial advisor — I am a retail investor who applies forensic analysis to my own portfolio and shares that process publicly. Nothing here constitutes a recommendation to buy, sell, or hold any security, and no specific target prices or personalised financial advice are offered. Stocks assessed under Iggy’s Forensic Yield Standard are benchmarked against a 4.7% minimum yield hurdle; stocks flagged as Growth Watch fall below this threshold but demonstrate clean balance sheet metrics and an identifiable growth catalyst — these carry a materially different risk profile and are not suitable as yield replacements for income-dependent investors. All data is sourced from public filings and verified sources; where data is unverified it is explicitly flagged. All investments carry risk, including the potential loss of principal, and past performance is not indicative of future results. If you are making investment decisions involving CPF, SRS, or personal capital, please conduct your own due diligence or consult a MAS-licensed financial adviser before committing funds.
